Psychedelic therapy: Will it be a game changer for mental health treatment? with Albert Garcia-Romeu, PhD
Speaking of Psychology
Do You Think That's a Good Idea?
Over 85% of participants in the clinical trials that to date have occurred using psilocybin and MDMA have been white. Culturally, I also think that there's a lot of mistrust of the medical institutions and biomedical research for a number of reasons. Less than 5% of people who are in trials of new FDA approved medications were coming from black African American Hispanic backgrounds. And so you're seeing, again, a very homogeneous population in many of these studies for any sort of medical research.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
